| Q38791734 | Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects |
| Q90427523 | Gene Therapy For Beta-Thalassemia: Updated Perspectives |
| Q45855613 | Gene therapy for homozygous beta-thalassemia. Is it a reality? |
| Q24595921 | Genetic modification of somatic stem cells. The progress, problems and prospects of a new therapeutic technology |
| Q36912757 | Has stem cell transplantation come of age in the treatment of sickle cell disease? |
| Q37024505 | Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future |
| Q37809343 | Hemoglobin Gene Therapy for β-Thalassemia |
| Q36969792 | Hemoglobin research and the origins of molecular medicine. |
| Q36802562 | In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia |
| Q28533770 | Information exploration system for sickle cell disease and repurposing of hydroxyfasudil |
| Q36543049 | Investigational agents for sickle cell disease |
| Q37069729 | Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells |
| Q35701287 | Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy |
| Q37935768 | Milestones in the history of hemoglobin research (in memory of professor Titus H.J. Huisman). |
| Q36848269 | Modern treatment of thalassaemia intermedia |
| Q38879274 | Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia-Current Status and Perspectives in Fetal Hemoglobin Reactivation. |
| Q38770436 | Non-invasive prenatal diagnosis of β-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis. |
| Q37623526 | Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation. |
| Q35723452 | Sickle cell disease: old discoveries, new concepts, and future promise |
| Q37053156 | Stem cells and genetic disease |
| Q37581606 | Targeted approaches for gene therapy and the emergence of engineered meganucleases |
| Q24618997 | Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia |